Research Topics
Genomes and Genes | Klaus FellermannSummaryCountry: Germany Publications
| Collaborators
|
Detail Information
Publications
Response of refractory colitis to intravenous or oral tacrolimus (FK506)Klaus Fellermann
Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany
Inflamm Bowel Dis 8:317-24. 2002..Renal impairment was rare and subsided upon drug withdrawal. In conclusion. FK506 is effective in the treatment of refractory colitis with per oral dosing being equivalent to intravenous administration...
Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Con argumentKlaus Fellermann
Department of Internal Medicine I, Robert Bosch Krankenhaus, Stuttgart, Germany
Inflamm Bowel Dis 9:198-201; discussion 202-4. 2003
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colonKlaus Fellermann
Department of Internal Medicine I, Robert Bosch Hospital, 70376 Stuttgart, Germany
Am J Hum Genet 79:439-48. 2006..033). In conclusion, a lower HBD-2 gene copy number in the beta-defensin locus predisposes to colonic CD, most likely through diminished beta-defensin expression...
Reduced mucosal antimicrobial activity in Crohn's disease of the colonSabine Nuding
Dr Margarete Fischer Bosch Institute of Clinical Pharmacology, Auerbachstr 112, 70376 Stuttgart, Germany
Gut 56:1240-7. 2007..To elucidate the possible functional consequences of this deficiency antimicrobial activity in colonic mucosa from patients with inflammatory bowel disease and healthy controls was investigated...
Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's diseaseMaureen J Koslowski
Dr Margarete Fischer Bosch Institute of Clinical Pharmacology, University of Tubingen, Stuttgart, Germany
PLoS ONE 4:e4496. 2009..38, 95% CI 1.03 to1.84, p = 0.02882). The newly identified genetic association of TCF-4 with ileal CD provides evidence that the decrease in Paneth cell alpha-defensins is a primary factor in disease pathogenesis...
Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellinMiriam Schlee
Dr Margarete Fischer Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
Infect Immun 75:2399-407. 2007..coli strain ATCC 25922. H1 flagellin antiserum abrogated hBD-2 expression induced by flagellin as well as E. coli Nissle 1917 supernatant, confirming that flagellin is the major stimulatory factor of E. coli Nissle 1917...
Crohn's disease--defect in innate defenceMichael Gersemann
Internal Medicine I, Robert Bosch Hospital, Auerbachstrasse 110, Stuttgart, Germany
World J Gastroenterol 14:5499-503. 2008..A better understanding of the exact molecular mechanisms behind ileal and colonic Crohn's disease may give rise to new therapeutic strategies based on a stimulation of the protective innate immune system...
Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitisKlaus R Herrlinger
Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany
Inflamm Bowel Dis 10:229-33. 2004..In addition, because standard laboratory inflammatory parameters are poorly correlated with disease activity in IBD, the relation between PCT levels and disease activity was investigated...
Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3Sabine Nuding
Dr Margarete Fischer Bosch Institute of Clinical Pharmacology Stuttgart and University of Tuebingen, Auerbachstr 112, 70376 Stuttgart, Germany
Microbes Infect 11:384-93. 2009..Thus, defensin resistance is not only species- but also strain-specific and may be clinically relevant in the host-bacteria interaction influencing mucosal translocation and systemic infection...
The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel diseaseFrauke Borcherding
Department of Internal Medicine I, University Hospital of Schleswig Holstein, Ratzeburger Allee 160, D 23538 Lubeck, Germany
Am J Pathol 176:1816-27. 2010..Our findings provide evidence for the epithelial expression and modulation of CD40 in IBD-affected mucosa and indicate its involvement in the proinflammatory function of IECs...
Cyclophosphamide therapy in Sweet's syndrome complicating refractory Crohn's disease − Efficacy and mechanism of actionChristian Meinhardt
Department of Internal Medicine I, University Hospital Schleswig Holstein, Campus Lubeck, Germany
J Crohns Colitis 5:633-7. 2011..The mechanism of action remains obscure. Here, we report about a case of steroid-refractory Sweet's syndrome accompanying Crohn's colitis treated by cyclophosphamide...
Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's diseaseMichael Schmid
Department of Internal Medicine I, Robert Bosch Hospital, Auerbachstr 112, 70376 Stuttgart, and Department of Dermatology, University of Kiel, Germany
J Leukoc Biol 81:907-15. 2007..This could contribute to the transmural depth of tissue destruction in CD. Elafin and SLPI may be added to the list of defensin-like peptides with diminished induction in CD versus UC...
A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extractsSabine Nuding
Dr Margarete Fischer Bosch Institute of Clinical Pharmacology, Robert Bosch Hospital, Auerbachstr 110, 73061 Stuttgart, Germany
J Microbiol Methods 65:335-45. 2006..coli at 150 mM NaCl, whereas the activity towards S. aureus ATCC 25923 remained unaffected at physiological salt concentrations. DTT blocked the bactericidal effect of biopsy extracts completely...
Differences in goblet cell differentiation between Crohn's disease and ulcerative colitisMichael Gersemann
Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany
Differentiation 77:84-94. 2009..Conspicuously, inflammation is associated with an enhanced goblet cell differentiation in CD but not in UC, a defect possibly of pathogenic importance...
Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel diseaseJan Wehkamp
Department of Internal Medicine I, Division of Gastroenterology, , Ratzeburger Allee 160, , Germany
Eur J Gastroenterol Hepatol 14:745-52. 2002..Defensins may play a crucial role in controlling pathogen invasion in IBD, although the functional significance remains to be established...
Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitisJan Wehkamp
Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany
Inflamm Bowel Dis 9:215-23. 2003..The missing induction of both inducible beta-defensins in CD as compared with UC may cause a defect in barrier function that predisposes to bacterial invasion...
Mesenteric pulsatility index analysis predicts response to azathioprine in patients with Crohn's diseaseNils Homann
Department of Internal Medicine I, Division of Gastroenterology, , , Germany
Inflamm Bowel Dis 11:126-32. 2005..Flow measurements in the IMA and postprandial values for both arteries were less reliable. CONCLUSION: Repeated DUS measurements of the SMA PI predict response to AZA/6-MP in patients with chronic active CD...
Crohn's targeted therapy: myth or real goal?Klaus J Schmidt
Department of Internal Medicine I, University Hospital of Schleswig Holstein, Ratzeburger Allee 160, D 23538 Lubeck, Germany
Curr Drug Discov Technol 6:290-8. 2009..Hence, targeted therapy in CD seems to be still a myth at present owing to the complex nature of disease...
NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacteriumJan Wehkamp
Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany
Infect Immun 72:5750-8. 2004..The induction of hBD-2 may contribute to an enhanced mucosal barrier to the luminal bacteria...
Crohn's disease: a defensin deficiency syndrome?Klaus Fellermann
Department of Internal Medicine I, Robert Bosch Krankenhaus, Stuttgart, Germany
Eur J Gastroenterol Hepatol 15:627-34. 2003..The hypothesis of an impaired mucosal antibacterial activity is also consistent with the benefit from antibiotic or probiotic treatment in certain inflammatory bowel disease states...
The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4Jan Wehkamp
Dr Margarete Fischer Bosch Institute of Clinical Pharmacology and University of Tübingen, Auerbachstrasse 12, Stuttgart, Germany
J Immunol 179:3109-18. 2007..This new link established between a human inflammatory bowel disease and the Wnt pathway/Tcf-4 provides a novel mechanism for pathogenesis in patients with ileal CD...
The expression patterns of peritoneal defensinsAlexander Grupp
Division of General Internal Medicine and Nephrology, Department of Internal Medicine, Robert Bosch Krankenhaus, Auerbachstrasse 110, Stuttgart, Germany
Perit Dial Int 27:654-62. 2007..Local defense mechanisms are important for the integrity of the peritoneum, but few details are known about the expression patterns of antimicrobial proteins such as human defensin in normal and damaged peritoneum...
Fatal staphylococcal sepsis in Crohn's disease after infliximabKlaus R Herrlinger
Department of Internal Medicine, Robert-Bosch-Hospital, Stuttgart, Germany
Inflamm Bowel Dis 10:655-6. 2004..After six infusions of infliximab, the patient developed staphylococcal pneumonia resulting in fatal adult respiratory distress syndrome. The case is discussed in the context of the toxicity profile of infliximab...
Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4Martin Nitschke
Department of Internal Medicine I, University Hospital Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
JAMA 307:1046-52. 2012..In the German outbreak, a substantial number of patients received prophylactic azithromycin treatment as part of a therapeutic regimen with the C5 antibody eculizumab...
Herpes simplex virus colitis complicating ulcerative colitis: A case report and brief review on superinfectionsMarco Oliver Schunter
Department of Gastroenterology and Hepatology, Robert Bosch Hospital, Auerbachstrasse 110, 70376 Stuttgart, Germany
J Crohns Colitis 1:41-6. 2007..Herpes simplex virus colitis is a rare but potentially fatal complication of immunosuppressive treatment in patients with inflammatory bowel disease. Prompt diagnosis and efficient antiviral therapy are mandatory to improve prognosis...
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseasesJürgen Schauber
Department of Medicine II, Division of Gastroenterology cInstitute of Pathology, University of Wurzburg, Germany
Eur J Gastroenterol Hepatol 18:615-21. 2006..In this study, the expression of human cathelicidin hCAP18/LL-37 was investigated in the intestinal mucosa from patients suffering from ulcerative colitis or Crohn's disease...
Reduced Paneth cell alpha-defensins in ileal Crohn's diseaseJan Wehkamp
Department of Microbiology and Immunology, School of Medicine, University of California, Davis, 95616, USA
Proc Natl Acad Sci U S A 102:18129-34. 2005..Thus, the specific deficiency of PC defensins that characterizes ileal CD may compromise innate immune defenses of the ileal mucosa and initiate and/or perpetuate this disease...
Human defensins in Crohn's diseaseJan Wehkamp
Department of Microbiology and Immunology, University of California, Davis, Calif, USA
Chem Immunol Allergy 86:42-54. 2005..The hypothesis of an impaired mucosal antibacterial activity is also consistent with the benefit from antibiotic or probiotic treatment in certain disease states...
Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing proteinSusanne Schinke
Department of Rheumatology, University of Luebeck, Bad Bramstedt, Germany
Inflamm Bowel Dis 10:763-70. 2004..Inhibition of the antibiotic function mediated by the N-terminal region of BPI by these autoantibodies may contribute to a proinflammatory environment in IBD patients...
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's diseaseJan Wehkamp
Department of Microbiology and Immunology, University of California, Davis, CA 95616, USA
J Leukoc Biol 77:460-5. 2005..Thus, it can be speculated that decreased defensin levels lead to a weakened intestinal barrier function to intestinal microbes and might be crucial in the pathophysiology of Crohn's disease...
6-thioguanine-buried alive?Klaus R Herrlinger
Gastroenterology 126:940-1; author reply 941-2. 2004
Antimicrobial peptides in the skinKlaus Fellermann
N Engl J Med 348:361-3; author reply 361-3. 2003
